Skip to main content
. 2022 Dec 2;12:20848. doi: 10.1038/s41598-022-24021-y

Figure 6.

Figure 6

The three-dimensional surface structure-forming complexes between the alpha-glucosidase (a) and acarbose (b; standard drug) with caulerpin. (c) Estrogen receptor alpha and caulerpin; (d) mitoxantrone (FDA approved drug) caulerpin complexe.